Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...

According to Kite, the median turnaround time for Yescarta is expected to be reduced from 16 days to 14 days. The Food and Drug Administration (FDA) has approved a manufacturing process change for ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

For patients with certain types of cancer, CAR T cell therapy has been nothing short of life changing. Developed in part by Carl June, Richard W. Vague Professor at Penn Medicine, and approved by the ...

A French company is seeking to solve one of the biggest challenges in the emerging cell therapy industry by commercializing an automated system for manufacturing CAR-T at scale. CellQuest, who has ...

Tesla’s unboxed process will transform car manufacturing and the cybercab will be revolunize transportation. They are so disruptive, they will need to have two major steps over two years. The first ...

AUSTIN, Texas, May 1 (Reuters) - Tesla (TSLA.O), opens new tab has backed away from an ambitious plan for innovations in gigacasting, its pioneering manufacturing process, according to two sources ...

Dongfeng Motor has officially signed a partnership with Ubtech Robotics for using its humanoid robots in tasks related to car manufacturing. With this partnership, Ubtech’s industrial version of the ...

Tesla has revealed its modular ‘unboxed’ EV manufacturing process that will be used in its upcoming Robotaxi in a new patent application. At Tesla’s 2023 Investor Day, the automaker unveiled a new car ...